Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now full pipeline small index

Seizure: full-pipeline trial registry

3 of 6 indexed Seizure trials are currently recruiting.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Seizure: 6 US clinical trials tracked, 3 recruiting.

Seizure is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Radiation Therapy Oncology Group, running 1 of these trials.

Enrollment posture brief

Registry condition seizure

OPEN 3 | RECR 50% | LATE 1 | EARLY 1 | RANK #2866 | SPON 1

Nearest open-share peer: Achalasia (50% recruiting · 8 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Seizure (this)50%
Open-enrollment share among volume-matched conditions near Seizure

Seizure lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Seizure on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Seizure is recruiting above its size-band peers.

    3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Seizure research.

    Radiation Therapy Oncology Group accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Seizure enrolment sits around 100 participants.

    Median target enrolment is 100 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.

  4. Seizure splits between interventional and observational designs.

    3 interventional and 3 observational studies make up this index (50% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21Phase 41

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 4 1

Named interventions

Most-linked intervention names on Seizure records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

magnetic resonance imaging Procedure
1 trials
cognitive assessment Procedure
1 trials
Modified Atkins or Ketogenic Diet Dietary supplement
1 trials
Medilepsy® Chatbot Standard Other
1 trials
Medilepsy® Chatbot AI-Enhanced Other
1 trials
RAP-219 Drug
1 trials
quality-of-life assessment Procedure
1 trials
questionnaire administration Other
1 trials

US sites by state

Facility locations filed on Seizure trials. A trial with sites in several states counts in each.

Missouri 2 trials
Minnesota 2 trials
Florida 2 trials
Texas 1 trials
Tennessee 1 trials
Pennsylvania 1 trials
Ohio 1 trials
New York 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Seizure page

6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Seizure condition card totals 6 registered trials; most-linked intervention magnetic resonance imaging; top US site state Missouri. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.